Jing-Yuan Cao Selected Research

Messenger RNA (mRNA)

3/2022

Urinary sediment CCL5 messenger RNA as a potential prognostic biomarker of diabetic nephropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jing-Yuan Cao Research Topics

Disease

7	Inflammation (Inflammations) 05/2023 - 01/2019
6	Fibrosis (Cirrhosis) 05/2023 - 01/2019
6	Hypoxia (Hypoxemia) 01/2023 - 12/2018
6	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2020
5	Neoplasms (Cancer) 01/2024 - 09/2019
3	Chronic Renal Insufficiency 01/2022 - 12/2018
3	Anemia 11/2020 - 12/2018
2	Genomic Instability 01/2024 - 01/2022
2	Ischemia 12/2022 - 10/2021
2	Kidney Diseases (Kidney Disease) 03/2022 - 07/2020
2	Ureteral Obstruction 10/2021 - 01/2021
2	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 09/2019
2	Glioma (Gliomas) 01/2020 - 09/2019
1	Reperfusion Injury 05/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 03/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 03/2022
1	Nephrolithiasis 01/2022
1	Dysbiosis 01/2022
1	Diabetes Complications 06/2021
1	Necrosis 01/2021
1	Carcinogenesis 09/2019
1	Secondary Hyperparathyroidism 07/2019
1	Hyperglycemia 01/2019
1	Iron Metabolism Disorders 12/2018
1	Hepatitis A (Hepatitis, Infectious) 12/2011

Drug/Important Bio-Agent (IBA)

3	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 01/2021
3	Prolyl-Hydroxylase InhibitorsIBA 01/2023 - 11/2019
3	Transcription Factors (Transcription Factor)IBA 10/2021 - 12/2018
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 01/2019
2	Oxygen (Dioxygen)IBA 01/2021 - 12/2018
1	Fibroblast Growth Factor 1 (FGF-1)IBA 01/2024
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2024
1	QuercetinIBA 05/2023
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2023
1	Uridine Diphosphate Glucose (UDP Glucose)IBA 01/2023
1	Glycogen Synthase (Synthase I)IBA 01/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2022
1	ElectrolytesIBA 10/2022
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 05/2022
1	roxadustatIBA 05/2022
1	Therapeutic UsesIBA 05/2022
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 05/2022
1	CreatinineIBA 03/2022
1	Biomarkers (Surrogate Marker)IBA 03/2022
1	Messenger RNA (mRNA)IBA 03/2022
1	AlbuminsIBA 03/2022
1	LigandsIBA 01/2022
1	ChemokinesIBA 01/2022
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022
1	Phosphorus (Red Phosphorus)IBA 01/2022
1	TensinsIBA 01/2022
1	Calcium OxalateIBA 01/2022
1	Peptides (Polypeptides)IBA 10/2021
1	ErbB Receptors (EGF Receptor)IBA 06/2021
1	Advanced Glycation End ProductsIBA 06/2021
1	Receptor for Advanced Glycation End ProductsIBA 06/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	HematinicsIBA 11/2020
1	InflammasomesIBA 07/2020
1	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 07/2020
1	A 68930IBA 07/2020
1	lymphocyte-specific protein p50IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	N- (bis(4- methoxyphenyl)methyl)- 4- hydroxy- 2- (pyridazin- 3- yl)pyrimidine- 5- carboxamideIBA 11/2019
1	Interleukin-6 (Interleukin 6)IBA 09/2019
1	Cytokine Receptors (Cytokine Receptor)IBA 09/2019
1	Oncostatin M Receptors (Oncostatin M Receptor)IBA 09/2019
1	Parathyroid Hormone (Parathormone)IBA 07/2019
1	Cinacalcet (Sensipar)FDA Link 07/2019
1	GlucocorticoidsIBA 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	Erythropoietin FDA Link 12/2018
1	AntigensIBA 12/2011

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2019